During the past decade, Hamatologische Sprechstunde conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hamatologische Sprechstunde" are "Leukemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Hamatologische Sprechstunde" in a lesser frequency.

Most popular intervention types in "Hamatologische Sprechstunde" are "Biological" (2 trials), "Drug" (2 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "allogeneic bone marrow transplantation" (1 trials), "autologous bone marrow transplantation" (1 trials), "cyclophosphamide" (1 trials), "cytarabine" (1 trials) and "doxorubicin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hamatologische Sprechstunde" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hamatologische Sprechstunde". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hamatologische Sprechstunde, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hamatologische Sprechstunde, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".